Andrew J Cohen1, Thomas W Gaither2, Sudarshan Srirangapatanam3, Erick R Castellanos3, Anthony Enriquez3, Kirkpatrick B Fergus3, Douglas Fadrosh4, Susan Lynch4, Nnenaya A Mmonu3, Benjamin N Breyer5,6. 1. James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. 2. Department of Urology, University of California, Los Angeles UCLA, Los Angeles, USA. 3. Department of Urology, Zuckerberg San Francisco General Hospital and Trauma Center, University of California-San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. 4. Department of Medicine-Gastroenterology, Microbiome Research Core, University of California-San Francisco, San Francisco, CA, USA. 5. Department of Urology, Zuckerberg San Francisco General Hospital and Trauma Center, University of California-San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. Benjamin.Breyer@ucsf.edu. 6. Department of Biostatistics and Epidemiology, University of California-San Francisco, San Francisco, CA, USA. Benjamin.Breyer@ucsf.edu.
Abstract
PURPOSE: Alterations in the urinary microbiome have been associated with urological diseases. The microbiome of patients with urethral stricture disease (USD) remains unknown. Our objective is to examine the microbiome of USD with a focus on inflammatory USD caused by lichen sclerosus (LS). METHODS: We collected mid-stream urine samples from men with LS-USD (cases; n = 22) and non-LS USD (controls; n = 76). DNA extraction, PCR amplification of the V4 hypervariable region of the 16S rRNA gene, and sequencing was done on the samples. Operational taxonomic units (OTUs) were defined using a > 97% sequence similarity threshold. Alpha diversity measurements of diversity, including microbiome richness (number of different OTUs) and evenness (distribution of OTUs) were calculated and compared. Microbiome beta diversity (difference between microbial communities) relationships with cases and controls were also assessed. RESULTS: Fifty specimens (13 cases and 37 controls) produced a 16S rRNA amplicon. Mean sample richness was 25.9 vs. 16.8 (p = 0.076) for LS-USD vs. non-LS USD, respectively. LS-USD had a unique profile of bacteria by taxonomic order including Bacillales, Bacteroidales and Pasteurellales enriched urine. The beta variation of observed bacterial communities was best explained by the richness. CONCLUSIONS: Men with LS-USD may have a unique microbiologic richness, specifically inclusive of Bacillales, Bacteroidales and Pasteurellales enriched urine compared to those with non-LS USD. Further work will be required to elucidate the clinical relevance of these variations in the urinary microbiome.
PURPOSE: Alterations in the urinary microbiome have been associated with urological diseases. The microbiome of patients with urethral stricture disease (USD) remains unknown. Our objective is to examine the microbiome of USD with a focus on inflammatory USD caused by lichen sclerosus (LS). METHODS: We collected mid-stream urine samples from men with LS-USD (cases; n = 22) and non-LS USD (controls; n = 76). DNA extraction, PCR amplification of the V4 hypervariable region of the 16S rRNA gene, and sequencing was done on the samples. Operational taxonomic units (OTUs) were defined using a > 97% sequence similarity threshold. Alpha diversity measurements of diversity, including microbiome richness (number of different OTUs) and evenness (distribution of OTUs) were calculated and compared. Microbiome beta diversity (difference between microbial communities) relationships with cases and controls were also assessed. RESULTS: Fifty specimens (13 cases and 37 controls) produced a 16S rRNA amplicon. Mean sample richness was 25.9 vs. 16.8 (p = 0.076) for LS-USD vs. non-LS USD, respectively. LS-USD had a unique profile of bacteria by taxonomic order including Bacillales, Bacteroidales and Pasteurellales enriched urine. The beta variation of observed bacterial communities was best explained by the richness. CONCLUSIONS:Men with LS-USD may have a unique microbiologic richness, specifically inclusive of Bacillales, Bacteroidales and Pasteurellales enriched urine compared to those with non-LS USD. Further work will be required to elucidate the clinical relevance of these variations in the urinary microbiome.
Authors: Scott R Bauer; Barbara Grimes; Anne M Suskind; Peggy M Cawthon; Steven Cummings; Alison J Huang Journal: J Urol Date: 2019-10-09 Impact factor: 7.450
Authors: Petar Bajic; Michelle E Van Kuiken; Bethany K Burge; Eric J Kirshenbaum; Cara J Joyce; Alan J Wolfe; Jeffrey D Branch; Larissa Bresler; Ahmer V Farooq Journal: Eur Urol Focus Date: 2018-08-22
Authors: Qunfeng Dong; David E Nelson; Evelyn Toh; Lixia Diao; Xiang Gao; J Dennis Fortenberry; Barbara Van der Pol Journal: PLoS One Date: 2011-05-13 Impact factor: 3.240
Authors: Maria Frølund; Arne Wikström; Peter Lidbrink; Waleed Abu Al-Soud; Niels Larsen; Christoffer Bugge Harder; Søren Johannes Sørensen; Jørgen Skov Jensen; Peter Ahrens Journal: PLoS One Date: 2018-07-27 Impact factor: 3.240
Authors: Lisa Pagan; Roos A M Ederveen; Bertine W Huisman; Jan W Schoones; Romy D Zwittink; Frank H J Schuren; Robert Rissmann; Jurgen M J Piek; Mariëtte I E van Poelgeest Journal: Microorganisms Date: 2021-12-12